TITLE

Considering Cannabis

AUTHOR(S)
Durand, Marcella; Holland, Nancy
PUB. DATE
June 2007
SOURCE
Inside MS;Jun/Jul2007, Vol. 25 Issue 3, p56
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on medical benefits offered by cannabinoids in marijuana for patients with multiple sclerosis (MS). Several studies on mice have found out that cannabinoids in marijuana have the potential to help manage MS symptoms such as pain and spasticity. Some of the cannabis derivatives that are tried to treat spasticity are cited. The adverse side effects associated with cannabinoids are mentioned.
ACCESSION #
25375660

 

Related Articles

  • Cannabinoids control spasticity and tremor in a multiple sclerosis model. Baker, David; Pryce, Gareth // Nature;3/2/2000, Vol. 404 Issue 6773, p84 

    Reveals that cannabinoids, such as tetrahydrocannabinol and methanandamide, control spasticity and tremor in a multiple sclerosis model. Chronic relapsing experimental allergic encephalomyelitis (CRAEA); CRAEA induction to myelin antigens; Perceived benefits of cannabis and alternative medicine.

  • Will Medicinal Cannabinoids Prove to be Useful Clinically? Smith, Paul F. // Current Drug Therapy;May2007, Vol. 2 Issue 2, p143 

    In some parts of the world, medicinal cannabinoids have already been used to treat nausea and vomiting associated with chemotherapy and wasting in diseases such as AIDS and terminal cancer. However, over the last several years, currently used cannabinoids, such as dronabinol, as well as newly...

  • Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain. Wissel, Jörg; Haydn, Tanja; Müller, Jörg; Schelosky, Ludwig D.; Brenneis, Christian; Berger, Thomas; Poewe, Werner // Journal of Neurology;Oct2006, Vol. 253 Issue 10, p1337 

    About 30% of patients with chronic upper motor neuron syndrome (UMNS) suffer from disabling spasticity-related pain not sufficiently correctable by conventional treatment. Delta9-tetrahydrocannabinol (Δ9-THC) was reported to add benefit in the treatment of pain in patients with multiple...

  • Cannabinoids Control Tremor and Spasticity in Experimental Multiple Sclerosis. Baker, David; Pryce, Gareth; Croxford, J. Ludovic; Brown, Peter; Pertwee, Roger G.; Makriyannis, Alex; Layward, Lorna; Di Marzo, Vincenzo // Multiple Sclerosis (13524585);Dec2000, Vol. 6 Issue 6, p412 

    Investigates the effectiveness and mechanisms of cannabinoids in alleviating spasticity and tremor in an experimental multiple sclerosis. How cannabinoids exerts its effects; Effect of augmentation in endocannabinoid levels on spasticity.

  • Cannabis use in multiple sclerosis. Ashfield, Tracey // Primary Health Care;Jul2005, Vol. 15 Issue 6, p25 

    Discusses the ethical and legal considerations for nurses caring for patients with multiple sclerosis (MS) who use cannabis for symptom relief in Great Britain. Skepticism among health professionals regarding the efficacy of cannabis despite its medicinal use for centuries; Indications showing...

  • Medical effects of cannabis. Williams, Tim // Pulse;2/23/2004, Vol. 64 Issue 8, p48 

    Discusses the medical effects of cannabis. Ways by which cannabis affect the brain; Three main cannabinoids responsible for cannabis effects; Range of cannabis potencies; Source of cannabis in Great Britain; Studies on the claimed therapeutic effect of cannabis on multiple sclerosis; Adverse...

  • The efficacy of multidisciplinary rehabilitation in stable multiple sclerosis patients. Storr, L. K.; Sørensen, P. S.; Ravnborg, M. // Multiple Sclerosis (13524585);Apr2006, Vol. 12 Issue 2, p235 

    Objective To evaluate the short-term efficacy of multidisciplinary, inpatient rehabilitation of multiple sclerosis (MS) patients. Methods A double-blind, randomized, parallel group design was used. The intervention group were offered comprehensive, multidisciplinary inpatient rehabilitation at...

  • Cannabis MS benefits 'subjective'  // Pulse;11/10/2003, Vol. 63 Issue 45, p7 

    Reports on the results of the randomized trial on cannabinoids as a treatment for multiple sclerosis in Great Britain. Mechanism underlying the treatment's action; Capacity of the treatment to improve mobility and pain control in multiple sclerosis; Safety profile in terms of general adverse events.

  • Cannabinoids might reduce spasticity in multiple sclerosis. Gottlieb, Scott // BMJ: British Medical Journal (International Edition);03/11/2000, Vol. 320 Issue 7236, p666 

    Presents a study on cannabinoids, the active ingredients found in marijuana which may help control the tremors and muscle spasticity in patients with multiple sclerosis. Methods used in the study; Comments from researcher David Baker; Study findings.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics